BU-NOT-SET

CONTACT US
The QbD approach: Key advantages in clinical and commercial phases
  • Analytical chemistry
Lab
Insight
Sustainability report 2020
  • Sustainability
Report
Report
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
  • Drug substance
Man at poster
Poster
Recipharm Analytical Solutions™
  • Analytical chemistry
Icon
Fact sheet
Impurity identification
  • Analytical chemistry
Woman inserting vials in machine
Fact sheet
Stability studies
  • Analytical chemistry
hand holding vials plate
Fact sheet
Extractables & leachables testing
  • Analytical chemistry
Product mix
Fact sheet
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
  • Industry trends
Eyes
Insight
Global expansion in the CDMO field
  • Industry trends
Eyes
Insight
Insight
  • Manufacturing
A strategic approach to pharmaceutical tech transfer
Insight
  • Manufacturing
Selecting Scalable Growth Media for Live Biotherapeutic Products
Insight
  • Drug product
  • Industry trends
Navigating the shifting landscape of oral solid dose manufacturing
Brochure
  • Manufacturing
Quality control service offering
Insight
  • Industry trends
Adapting to the new rules of the CDMO game
Insight
  • Drug product
  • Manufacturing
Exploring alternative container formats in ophthalmic drug delivery
Fact sheet
  • Drug product
  • Manufacturing
ReciPredict - Value by Design
Poster
  • Drug substance
Innovative ALS Tablet Development
Insight
  • Drug product
  • Manufacturing
How Blow-fill-seal (BFS) technology may be a superior alternative to glass vials during the early stages of a development project